Sarcopenia: Revised European consensus on definition and diagnosis
Citations
2,287 citations
505 citations
466 citations
Cites methods from "Sarcopenia: Revised European consen..."
...Of importance, the task force did consider grip strength as a screening tool for sarcopenia, but this was voted out in the consensus process for two main reasons: (i) the new EWGSOP guidelines for sarcopenia [EWGSOP-2 (59)] recommend that grip strength is a diagnostic assessment rather than a screening test; and (ii) the specific feedback we received from the primary care members of our external reviewing group, most of whom stated that they would prefer not to perform grip strength measurement in their primary care clinics....
[...]
421 citations
References
100 citations
"Sarcopenia: Revised European consen..." refers background in this paper
...…Resonance Imaging (MRI, total body protocoI) Shen (2004) [44] Sergi (2017) [45] Maden-Wilkinson (2013) [46] Heymsfield (1990) [47] Kim (2002) [48] Yamada (2017) [49] Mid-thigh muscle cross-sectional area by Computed Tomography (CT) or MRI Lee (2004) [50] Lumbar muscle cross-sectional area by CT…...
[...]
98 citations
95 citations
"Sarcopenia: Revised European consen..." refers background in this paper
...Sarcopenia is now formally recognised as a muscle disease with an ICD-10-MC Diagnosis Code that can be used to bill for care in some countries [7, 8]....
[...]
92 citations
"Sarcopenia: Revised European consen..." refers background in this paper
...The TUG has also been found to predict mortality [92]....
[...]
88 citations
"Sarcopenia: Revised European consen..." refers background in this paper
...Optimal care for people with sarcopenia is essential because the condition has high personal, social and economic burdens when untreated [9]....
[...]
...In a study of older people in the community, in assisted-living facilities, or in residential living facilities, researchers found that lower gait speed and chair stand were potential drivers of disability in activities of daily living (ADL) and that such disability was associated with lower quality of life (QoL) and higher healthcare costs in these target groups [9]....
[...]